Order byBest matchMost fresh
FDA announces plans to restrict access for COVID vaccines
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
FDA offers new guidelines to shift COVID vaccine focus to high-risk groups
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over the age of 65 years and for all persons above the age of 6 months with
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.”
Trump Administration Toughens Requirements for Covid Vaccine Approval
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
MAHA Influencer Slams Trump Admin COVID Vaccine Update—'Really Unfortunate'
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
FDA to limit covid shot approval to elderly, those with medical conditions
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
Feedback